{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T03:08:36Z","timestamp":1789873716229,"version":"4.0.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T00:00:00Z","timestamp":1620777600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Forensic Science International"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.forsciint.2021.110830","type":"journal-article","created":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T02:23:44Z","timestamp":1620872624000},"page":"110830","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Pregabalin and gabapentin in non-opioid poisoning deaths"],"prefix":"10.1016","volume":"324","author":[{"given":"Pirkko","family":"Kriikku","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilkka","family":"Ojanper\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.forsciint.2021.110830_bib1","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s00228-010-0853-y","article-title":"A signal for an abuse liability for pregabalin\u2014Results from the Swedish spontaneous adverse drug reaction reporting system","volume":"66","author":"Schwan","year":"2010","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.forsciint.2021.110830_bib2","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMp1704633","article-title":"Gabapentin and pregabalin for pain\u2014Is increased prescribing a cause for concern?","volume":"377","author":"Goodman","year":"2017","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.forsciint.2021.110830_bib3","unstructured":"E. Lynn, Has an Increase in the Dispensing of Pregabalin Influenced Poisoning Deaths in Ireland? Drug Irel, 71, 2019, pp. 15\u201317."},{"key":"10.1016\/j.forsciint.2021.110830_bib4","unstructured":"Finnish Medicines Agency, Drug consumption reports. Available at \u3008https:\/\/www.fimea.fi\/web\/en\/databases_and_registeries\/consumption\u3009 (Accessed 15th January 2021)."},{"key":"10.1016\/j.forsciint.2021.110830_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.forsciint.2014.04.028","article-title":"Profiles of pregabalin and gabapentin abuse by post-mortem toxicology","volume":"241","author":"H\u00e4kkinen","year":"2014","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2021.110830_bib6","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s40263-014-0164-4","article-title":"Misuse and abuse of pregabalin and gabapentin: cause for concern?","volume":"28","author":"Schifano","year":"2014","journal-title":"CNS Drugs"},{"key":"10.1016\/j.forsciint.2021.110830_bib7","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/add.13324","article-title":"Gabapentin misuse, abuse and diversion: a systematic review","volume":"111","author":"Smith","year":"2016","journal-title":"Addiction"},{"key":"10.1016\/j.forsciint.2021.110830_bib8","first-page":"1","article-title":"Abuse and misuse of pregabalin and gabapentin: a systematic review update","author":"Evoy","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.forsciint.2021.110830_bib9","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/add.14412","article-title":"Rising pregabalin use and misuse in Australia: trends in utilization and intentional poisonings","volume":"114","author":"Cairns","year":"2019","journal-title":"Addiction"},{"key":"10.1016\/j.forsciint.2021.110830_bib10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000355268","article-title":"Gabapentinoid abuse in order to potentiate the effect of methadone: a survey among substance misusers","volume":"20","author":"Baird","year":"2014","journal-title":"Eur. Addict. Res."},{"key":"10.1016\/j.forsciint.2021.110830_bib11","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1176\/appi.ajp.2014.13111526","article-title":"Potentiation of the effect of buprenorphine\/naloxone with gabapentin or quetiapine","volume":"171","author":"Reeves","year":"2014","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.forsciint.2021.110830_bib12","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000321079","article-title":"Is there a recreational misuse potential for pregabalin? Analysis of anecdotal online reports in comparison with related gabapentin and clonazepam data","volume":"80","author":"Schifano","year":"2011","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.forsciint.2021.110830_bib13","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s40263-017-0467-3","article-title":"Pregabalin use among users of illicit drugs: a cross-sectional survey in Southern Germany","volume":"31","author":"Snellgrove","year":"2017","journal-title":"CNS Drugs"},{"key":"10.1016\/j.forsciint.2021.110830_bib14","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2165\/11536200-000000000-00000","article-title":"A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin","volume":"49","author":"Bockbrader","year":"2010","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.forsciint.2021.110830_bib15","doi-asserted-by":"crossref","first-page":"8463","DOI":"10.1007\/s00216-013-7272-8","article-title":"A high sensitivity ultra-high performance liquid chromatography\/high-resolution time-of-\ufb02ight mass spectrometry (UHPLC-HR-TOFMS) method for screening synthetic cannabinoids and other drugs of abuse in urine","volume":"405","author":"Sundstr\u00f6m","year":"2013","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.forsciint.2021.110830_bib16","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/01.ftd.0000158874.54100.1a","article-title":"Analysis of pregabalin at therapeutic concentrations in human plasma\/serum by reversed-phase HPLC","volume":"27","author":"Berry","year":"2005","journal-title":"Ther. Drug. Monit."},{"key":"10.1016\/j.forsciint.2021.110830_bib17","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1528-1167.2008.01561.x","article-title":"Antiepileptic drugs\u2014Best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies","volume":"49","author":"Patsalos","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.forsciint.2021.110830_bib18","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/1556-4029.13263","article-title":"Determining the toxicological significance of pregabalin in fatalities","volume":"62","author":"Elliott","year":"2017","journal-title":"J. Forensic Sci."},{"key":"10.1016\/j.forsciint.2021.110830_bib19","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.forsciint.2016.05.033","article-title":"Pregabalin concentrations in post-mortem blood\u2014A two year study","volume":"266","author":"Eastwood","year":"2016","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2021.110830_bib20","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1111\/j.1556-4029.2011.01798.x","article-title":"Suicide by gabapentin overdose","volume":"56","author":"Middleton","year":"2011","journal-title":"J. Forensic Sci."},{"key":"10.1016\/j.forsciint.2021.110830_bib21","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00414-015-1193-3","article-title":"An acute gabapentin fatality: a case report with post-mortem concentrations","volume":"129","author":"Cantrell","year":"2015","journal-title":"Int. J. Leg. Med."},{"key":"10.1016\/j.forsciint.2021.110830_bib22","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.forsciint.2014.06.030","article-title":"Pregabalin serum levels in apprehended drivers","volume":"243","author":"Kriikku","year":"2014","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2021.110830_bib23","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.forsciint.2016.03.028","article-title":"Gabapentin concentrations and post-mortem distribution","volume":"262","author":"Hamm","year":"2016","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2021.110830_bib24","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1002\/dta.2655","article-title":"Summary statistics for drug concentrations in post\u2010mortem femoral blood representing all causes of death","volume":"11","author":"Ketola","year":"2019","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.forsciint.2021.110830_bib25","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2165\/11536200-000000000-00000","article-title":"A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin","volume":"49","author":"Bockbrader","year":"2010","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.forsciint.2021.110830_bib26","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/add.14014","article-title":"Non\u2010medical use of psychoactive prescription drugs is associated with fatal poisoning","volume":"113","author":"Haukka","year":"2018","journal-title":"Addiction"},{"key":"10.1016\/j.forsciint.2021.110830_bib27","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bja.2020.05.017","article-title":"Trends in gabapentinoid prescribing, co-prescribing of opioids and benzodiazepines, and associated deaths in Scotland","volume":"125","author":"Torrance","year":"2020","journal-title":"Br. J. Anaesth."}],"container-title":["Forensic Science International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037907382100150X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037907382100150X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T18:04:29Z","timestamp":1759946669000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S037907382100150X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":27,"alternative-id":["S037907382100150X"],"URL":"https:\/\/doi.org\/10.1016\/j.forsciint.2021.110830","relation":{},"ISSN":["0379-0738"],"issn-type":[{"value":"0379-0738","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pregabalin and gabapentin in non-opioid poisoning deaths","name":"articletitle","label":"Article Title"},{"value":"Forensic Science International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.forsciint.2021.110830","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110830"}}